Currently, people are cognitively tested for Alzheimer’s only when symptoms have progressed to a point where the disease overtakes many aspects of daily life. Research shows Alzheimer’s can begin way before the first outward signs.
“We need a better way of diagnosing Alzheimer’s — like a simple blood test or eye exam — before we’re able to slow the progression of the disease,” Mr. Gates said. “Imagine a world where diagnosing Alzheimer’s disease is as simple as getting your blood tested during your annual physical.”
The venture fund will support cutting-edge research on a diagnostic test.
The fund also is backed by Estee Lauder cosmetic billionaires Leonard and Ronald Lauder; the Charles and Helen Schwab Foundation; and Dolby Family Ventures, among others.
More articles on population health:
CDC joins investigation into sonic attacks in Cuba, China
House rejects proposal to give CDC $10M for gun violence research
Compulsive sexual behavior is a mental health disorder, WHO says
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
